Masitinib in the Treatment of Active Rheumatoid Arthritis: Results of a Multicentre, Open-Label, Dose-Ranging, Phase 2a Study

Arthritis Research and Therapy - United Kingdom
doi 10.1186/ar2740
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Beclomethasone Dipropionate in Microscopic Colitis: Results of an Exploratory Open-Label Multicentre Study (COLCO)

United European Gastroenterology Journal
OncologyGastroenterology
2019English

Safety and Efficacy of Tofacitinib for Up to 9.5 Years in the Treatment of Rheumatoid Arthritis: Final Results of a Global, Open-Label, Long-Term Extension Study

Arthritis Research & Therapy
2019English

Treatment of Diaphragmatic Fatigue With Inhaled Aminophylline Therapy in an Experimental Canine Model: An Open-Label, Dose-Ranging, Pharmacologic Study

Current Therapeutic Research
Pharmacology
2003English

Evaluation of Low-Dose Tablet Buccilamine (Rimatils 50) in the Treatment of Active Adult Rheumatoid Arthritis.

Ensho
1993English

Late Results of Gold Treatment in Rheumatoid Arthritis

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1952English

A Phase 1b/2, Open-Label, Dose-Escalation, and Dose-Confirmation Study of Eribulin Mesilate in Combination With Capecitabine

British Journal of Cancer
Cancer ResearchOncology
2019English

Efficacy of a Standardized Herbal Preparation (Roidosanal®) in the Treatment of Hemorrhoids: A Randomized, Controlled, Open-Label Multicentre Study

Journal of Ayurveda and Integrative Medicine
Drug DiscoveryAlternative MedicineComplementary
2014English

Influence of Rituximab on Markers of Bone Remodeling in Patients With Rheumatoid Arthritis: A Prospective Open-Label Pilot Study

Rheumatology International
RheumatologyAllergyImmunology
2010English

A Multicentre Open-Label Safety and Efficacy Study of Tetrodotoxin for Cancer Pain

Current Oncology
Oncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy